Literature DB >> 11752008

Selective activation of cervical microvascular endothelial cells by human papillomavirus 16-e7 oncoprotein.

R D'Anna1, H Le Buanec, G Alessandri, A Caruso, A Burny, R Gallo, J F Zagury, D Zagury, P D'Alessio.   

Abstract

BACKGROUND: Human papillomavirus type 16 (HPV16) is strongly implicated in the etiology of cervical cancer, with the expression of HPV16-encoded E7 oncoprotein in infected epithelial cells contributing to their malignant transformation. Although nuclear E7 interacts with several nuclear targets, we have previously shown that extracellular E7 can cause suppression of immune cell function. Moreover, cervical microvascular endothelial (CrMVEn) cells treated with E7 increase their expression of adhesion molecules. High levels of some cytokines in serum and in cervicovaginal secretions are associated with the progression of cervical cancer. In this study, we investigated the effects of extracellular E7 on cytokine production and on cytoskeleton structure of CrMVEn cells and vascular endothelial cells from different organs.
METHODS: Immunocytochemical staining and flow cytometry techniques were used to detect E7 in endothelial cells incubated with purified E7 protein. Laser scanning confocal microscopy was used to study the E7-induced modification of the endothelial cytoskeleton. An enzyme-linked immunosorbent assay was performed to measure the production of two cytokines, interleukin 6 (IL-6) and interleukin 8 (IL-8), by E7-treated endothelial cells. All statistical tests were two-sided.
RESULTS: Extracellular E7 was taken up by CrMVEn cells and localized to the cytoplasm. CrMVEn cells showed a statistically significant (P<.02) increase in the production of IL-6 and IL-8 after treatment with E7 compared with the controls. CrMVEn cells also produced higher levels of these cytokines than did the other endothelial cells (P<.01). E7 also induced marked alterations in the endothelial cytoskeleton of CrMVEn cells as a result of actin fiber polymerization.
CONCLUSION: These findings suggest a novel mechanism by which E7, as an extracellular factor, can play a role in the progression and dissemination of cervical cancer via its selective effects on endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11752008     DOI: 10.1093/jnci/93.24.1843

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  4 in total

1.  VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases.

Authors:  Farhad Haghighi Rad; Hélène Le Buanec; Sébastien Paturance; Patrick Larcier; Philippe Genne; Bernhard Ryffel; Armand Bensussan; Bernard Bizzini; Robert C Gallo; Daniel Zagury; Georges Uzan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-14       Impact factor: 11.205

2.  Further Stimulation of Cellular Immune Responses through Association of HPV-16 E6, E7 and L1 Genes in order to produce more Effective Therapeutic DNA Vaccines in Cervical Cancer Model.

Authors:  Maryam Fazeli; Hoorieh Soleimanjahi; Simin Dadashzadeh
Journal:  Iran J Cancer Prev       Date:  2015 Jan-Feb

Review 3.  Human Papillomavirus and the Stroma: Bidirectional Crosstalk during the Virus Life Cycle and Carcinogenesis.

Authors:  Megan E Spurgeon; Paul F Lambert
Journal:  Viruses       Date:  2017-08-09       Impact factor: 5.048

Review 4.  In Vitro Organotypic Systems to Model Tumor Microenvironment in Human Papillomavirus (HPV)-Related Cancers.

Authors:  Vincenza De Gregorio; Francesco Urciuolo; Paolo Antonio Netti; Giorgia Imparato
Journal:  Cancers (Basel)       Date:  2020-05-03       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.